# Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection

> **NCT07429162** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Alberta Health services** · enrollment: 1 (estimated)

## Conditions studied

- Mycobacterium Abscessus Infection
- Bacteriophage Therapy
- Pulmonary Disease

## Interventions

- **BIOLOGICAL:** DP-QB-MYA-002

## Key facts

- **NCT ID:** NCT07429162
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-02
- **Primary completion:** 2027-07-02
- **Final completion:** 2028-07-02
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07429162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07429162, "Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07429162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*